In the second trial, also in a murine model, in which over-expression of the modified human TNF-α gene to prevent degradation of its mRNA is associated with the development of RA 4–6 months after the birth of the animals, the administration of anti-TNF-α demonstrated the prevention of arthritis [16]. Here, TNF is linked to rheumatoid arthritis.